Financhill
Back

UroGen Pharma Vs. Arbutus Biopharma Industry Stock Comparison

Sell
43

URGN
UroGen Pharma

Last Price:
11.36
Seasonality Move:
5.08%
Sell
29

ABUS
Arbutus Biopharma

Last Price:
3.49
Seasonality Move:
19.93%
Sell
43
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $11.47. The Score for URGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.48. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $11.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 39.41 Sell
Chaikin Money Flow: 14788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 41.86 Sell
Chaikin Money Flow: -242033 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.45 - 3.69) Sell
Bollinger Bands (100): (3.59 - 4.11) Sell

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.05 Sell
20-day SMA: 11.99 Sell
50-day SMA: 12.21 Sell
200-day SMA: 14.16 Sell
8-day EMA: 11.93 Sell
20-day EMA: 12.08 Sell
50-day EMA: 12.39 Sell
200-day EMA: 13.6 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.65 Sell
20-day SMA: 3.54 Sell
50-day SMA: 3.75 Sell
200-day SMA: 3.43 Buy
8-day EMA: 3.59 Sell
20-day EMA: 3.61 Sell
50-day EMA: 3.7 Sell
200-day EMA: 3.45 Buy

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):